|
CCDC142 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.12649997610725E-09 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.34639999149755E-09 |
| Stage1-vs-Stage2 |
6.692800E-01 |
| Stage1-vs-Stage3 |
2.248100E-02 |
| Stage1-vs-Stage4 |
6.388000E-01 |
| Stage2-vs-Stage3 |
3.671000E-01 |
| Stage2-vs-Stage4 |
9.793800E-01 |
| Stage3-vs-Stage4 |
3.768400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.12789999998186E-06 |
| Normal-vs-Asian |
3.09629999417638E-09 |
| Caucasian-vs-AfricanAmerican |
5.183000E-01 |
| Caucasian-vs-Asian |
5.292000E-01 |
| AfricanAmerican-vs-Asian |
8.847000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.37587727269783E-14 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.181400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.25823828922967E-12 |
| Normal-vs-Age(81-100Yrs) |
2.67109999674275E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.622400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.200000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.731800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.578600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.102000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.416200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.20979998136295E-09 |
| Classical-VS-Follicular |
3.423400E-01 |
| Classical-VS-Other |
8.916000E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
2.237800E-04 |
| Tall-VS-Other |
1.628830E-01 |
| Tall-VS-Normal |
1.62447832963153E-12 |
| Follicular-VS-Other |
8.508600E-01 |
| Follicular-VS-Normal |
1.53650425716023E-11 |
| Other-VS-Normal |
1.957680E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77635683940025E-15 |
| Normal-vs-N1 |
1.14660003713851E-09 |
| N0-vs-N1 |
9.679400E-01 |
|
|
